OpenURL Connection Search

Select item for more details and to access through your institution.

First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.
Published in:
Annals of Hematology, 2022, v. 101, n. 11, p. 2405, doi. 10.1007/s00277-022-04952-2
By:
- Hu, Jing;
- Zhang, Li;
- Zhao, Xin;
- Liu, Xu;
- Jing, Liping;
- Zhou, Kang;
- Li, Yuan;
- Li, Yang;
- Li, Jianping;
- Ye, Lei;
- Peng, Guangxin;
- Fan, Huihui;
- Yang, Wenrui;
- Yang, Yang;
- Xiong, Youzhen;
- Song, Lin;
- Zhang, Fengkui
Publication type:
Article
Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1175048
By:
- Xu Liu;
- Wenrui Yang;
- Li Zhang;
- Liping Jing;
- Lei Ye;
- Kang Zhou;
- Yuan Li;
- Jianping Li;
- Huihui Fan;
- Yang Yang;
- Youzhen Xiong;
- Xin Zhao
Publication type:
Article
Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study.
Published in:
Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207221146031
By:
- Yang, Wenrui;
- Liu, Xu;
- Zhao, Xin;
- Zhang, Li;
- Peng, Guangxin;
- Ye, Lei;
- Zhou, Kang;
- Li, Yuan;
- Li, Jianping;
- Fan, Huihui;
- Yang, Yang;
- Xiong, Youzhen;
- Jing, Liping;
- Zhang, Fengkui
Publication type:
Article
Genotype-degree of hemolysis correlation in hereditary spherocytosis.
Published in:
BMC Genomics, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12864-023-09364-8
By:
- Shi, Yimeng;
- Li, Yuan;
- Yang, Xiawan;
- Li, Xiaoxia;
- Peng, Guangxin;
- Zhao, Xin;
- Liu, Xu;
- Zhao, Yufei;
- Hu, Jing;
- Hu, Xiangrong;
- Zhang, Baohang;
- Zhou, Kang;
- Yang, Yang;
- Xiong, Youzhen;
- Li, Jianping;
- Fan, Huihui;
- Yang, Wenrui;
- Ye, Lei;
- Jing, Liping;
- Zhang, Li
Publication type:
Article
Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study.
Published in:
Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00377-3
By:
- Yang, Wenrui;
- Zhao, Xin;
- Liu, Xu;
- Xiong, Youzhen;
- Fan, Huihui;
- Zhang, Li;
- Li, Jianping;
- Ye, Lei;
- Zhou, Kang;
- Li, Yuan;
- Yang, Yang;
- Peng, Guangxin;
- Jing, Liping;
- Zhang, Fengkui
Publication type:
Article

Found: 5

First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years' experience.

Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia.

Antihuman T lymphocyte porcine immunoglobulin combined with cyclosporine as first-line immunosuppressive therapy for severe aplastic anemia in China: a large single-center, 10-year retrospective study.

Genotype-degree of hemolysis correlation in hereditary spherocytosis.

Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study.